Kalus JS - Search Results

1

Clinical and safety impact of an inpatient pharmacist-directed anticoagulation service.

Schillig J, Kaatz S, Hudson M, Krol GD, Szandzik EG, Kalus JS. Schillig J, et al. Among authors: kalus js. J Hosp Med. 2011 Jul-Aug;6(6):322-8. doi: 10.1002/jhm.910. J Hosp Med. 2011. PMID: 21834113 Clinical Trial.

2

Nontraditional pharmacy residency at a large teaching hospital.

Winegardner ML, Davis SL, Szandzik EG, Kalus JS. Winegardner ML, et al. Among authors: kalus js. Am J Health Syst Pharm. 2010 Mar 1;67(5):366-70. doi: 10.2146/ajhp070499. Am J Health Syst Pharm. 2010. PMID: 20172986

3

Impact of a Pharmacist-Directed Anticoagulation Service on the Quality and Safety of Heparin-Induced Thrombocytopenia Management.

To L, Schillig JM, DeSmet BD, Kuriakose P, Szandzik EG, Kalus JS. To L, et al. Among authors: kalus js. Ann Pharmacother. 2011 Feb;45(2):195-200. doi: 10.1345/aph.1P503. Ann Pharmacother. 2011. PMID: 21304024

4

The impact of pharmacist-directed patient education and anticoagulant care coordination on patient satisfaction.

Makowski CT, Jennings DL, Nemerovski CW, Szandzik EG, Kalus JS. Makowski CT, et al. Among authors: kalus js. Ann Pharmacother. 2013 Jun;47(6):805-10. doi: 10.1345/aph.1R686. Epub 2013 May 8. Ann Pharmacother. 2013. PMID: 23656752

5

Variations in pharmacy-based transition-of-care activities in the United States: a national survey.

Kern KA, Kalus JS, Bush C, Chen D, Szandzik EG, Haque NZ. Kern KA, et al. Among authors: kalus js. Am J Health Syst Pharm. 2014 Apr 15;71(8):648-56. doi: 10.2146/ajhp130510. Am J Health Syst Pharm. 2014. PMID: 24688039

6

Pharmacist hypertension management using an electronic health record-based approach.

Soreide KK, Solomon O, Farhat NM, Kolander S, Gottschall T, George DL, Szandzik EG, Kalus JS, Thomas E. Soreide KK, et al. Among authors: kalus js. Am J Manag Care. 2022 Apr 1;28(4):e121-e125. doi: 10.37765/ajmc.2022.88864. Am J Manag Care. 2022. PMID: 35420749 Free article.

7

Management of bleeding and reversal strategies for oral anticoagulants: clinical practice considerations.

Nutescu EA, Dager WE, Kalus JS, Lewin JJ 3rd, Cipolle MD. Nutescu EA, et al. Among authors: kalus js. Am J Health Syst Pharm. 2013 Nov 1;70(21):1914-29. doi: 10.2146/ajhp130243. Am J Health Syst Pharm. 2013. PMID: 24128967 Review.

8

Impact of Platelet Functional Assays on the Cost of Treating Suspected Heparin-Induced Thrombocytopenia.

Sadik ZG, Jennings DL, Nemerovski CW, Kuriakose P, Kalus JS. Sadik ZG, et al. Among authors: kalus js. J Pharm Pract. 2015 Aug;28(4):398-403. doi: 10.1177/0897190014522065. Epub 2014 Feb 14. J Pharm Pract. 2015. PMID: 24532821

9

Overview of betrixaban and its role in clinical practice.

Lekura J, Kalus JS. Lekura J, et al. Among authors: kalus js. Am J Health Syst Pharm. 2018 Aug 1;75(15):1095-1102. doi: 10.2146/ajhp170785. Epub 2018 Jun 25. Am J Health Syst Pharm. 2018. PMID: 29941506 Review.

10

Pharmacologic management of atrial fibrillation: established and emerging options.

Kalus JS. Kalus JS. J Manag Care Pharm. 2009 Aug;15(6 Suppl B):S10-8. doi: 10.18553/jmcp.2009.15.s6-b.10. J Manag Care Pharm. 2009. PMID: 19678722 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters